About Chestnut Medical
Chestnut Medical is a company based in Menlo Park (United States) founded in 2003 was acquired by ev3 Endovascular in June 2009.. Chestnut Medical has raised $7.8 million across 1 funding round from investors including ev3 Endovascular, Japan Asia Investment and ITX International Holdings. Chestnut Medical offers products and services including Metal Targets and Target Stand. Chestnut Medical operates in a competitive market with competitors including Rapid Medical, Fluid Biomed, Cerus Endovascular, Oxford Endovascular and Anaconda Biomed, among others.
- Headquarter Menlo Park, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$7.8 M (USD)
in 1 rounds
-
Latest Funding Round
$7.8 M (USD), Series A
Mar 15, 2008
-
Investors
ev3 Endovascular
& 2 more
-
Employee Count
Employee Count
-
Acquired by
ev3 Endovascular
(Jun 02, 2009)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Chestnut Medical
Chestnut Medical offers a comprehensive portfolio of products and services, including Metal Targets and Target Stand. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Durable tools for safe gun practice and skill enhancement.
Support structure for hanging targets during shooting sessions.
Funding Insights of Chestnut Medical
Chestnut Medical has successfully raised a total of $7.8M through 1 strategic funding round. The most recent funding activity was a Series A round of $7.8 million completed in March 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $7.8M
-
First Round
First Round
(15 Mar 2008)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2008 | Amount | Series A - Chestnut Medical | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Chestnut Medical
Chestnut Medical has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include ev3 Endovascular, Japan Asia Investment and ITX International Holdings. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Private equity platform is operated for investing in growth-oriented companies.
|
Founded Year | Domain | Location | |
|
Surgical products for treatment of Peripheral vascular & Neurovascular diseases
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Chestnut Medical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Chestnut Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Chestnut Medical Comparisons
Competitors of Chestnut Medical
Chestnut Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rapid Medical, Fluid Biomed, Cerus Endovascular, Oxford Endovascular and Anaconda Biomed, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurovascular interventional devices including distal access catheters are developed.
|
|
| domain | founded_year | HQ Location |
A hybrid polymer-metal stent for brain aneurysms is developed.
|
|
| domain | founded_year | HQ Location |
Interventional neuroradiology devices are developed for minimally invasive aneurysm treatment.
|
|
| domain | founded_year | HQ Location |
Metallic mesh devices for brain aneurysms are developed.
|
|
| domain | founded_year | HQ Location |
Medical devices for mechanical thromboectomy and clot removal are developed.
|
|
| domain | founded_year | HQ Location |
Neuroendovascular technologies for cerebral and peripheral vascular diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Chestnut Medical
When was Chestnut Medical founded?
Chestnut Medical was founded in 2003 and raised its 1st funding round 5 years after it was founded.
Where is Chestnut Medical located?
Chestnut Medical is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Is Chestnut Medical a funded company?
Chestnut Medical is a funded company, having raised a total of $7.8M across 1 funding round to date. The company's 1st funding round was a Series A of $7.8M, raised on Mar 15, 2008.
What does Chestnut Medical do?
Chestnut Medical Technologies was founded in 2003 in Menlo Park, United States, with a focus on medical devices for interventional neuroradiology. The Alligator retrieval device was developed to remove blood clots and foreign bodies from blood vessels using a catheter-based clamp. FDA approval for the product was obtained in 2005. Operations centered on minimally invasive solutions until acquisition by EV3 in 2009.
Who are the top competitors of Chestnut Medical?
Chestnut Medical's top competitors include Rapid Medical, Fluid Biomed and Anaconda Biomed.
What products or services does Chestnut Medical offer?
Chestnut Medical offers Metal Targets and Target Stand.
Who are Chestnut Medical's investors?
Chestnut Medical has 3 investors. Key investors include ev3 Endovascular, Japan Asia Investment, and ITX International Holdings.